Matches in Wikidata for { <http://www.wikidata.org/entity/Q81604961> ?p ?o ?g. }
- Q81604961 description "2005 nî lūn-bûn" @default.
- Q81604961 description "2005年の論文" @default.
- Q81604961 description "2005年学术文章" @default.
- Q81604961 description "2005年学术文章" @default.
- Q81604961 description "2005年学术文章" @default.
- Q81604961 description "2005年学术文章" @default.
- Q81604961 description "2005年学术文章" @default.
- Q81604961 description "2005年学术文章" @default.
- Q81604961 description "2005年學術文章" @default.
- Q81604961 description "2005年學術文章" @default.
- Q81604961 description "2005年學術文章" @default.
- Q81604961 description "2005年學術文章" @default.
- Q81604961 description "2005年學術文章" @default.
- Q81604961 description "2005년 논문" @default.
- Q81604961 description "article científic" @default.
- Q81604961 description "article scientific" @default.
- Q81604961 description "article scientifique" @default.
- Q81604961 description "articol științific" @default.
- Q81604961 description "articolo scientifico" @default.
- Q81604961 description "artigo científico" @default.
- Q81604961 description "artigo científico" @default.
- Q81604961 description "artigo científico" @default.
- Q81604961 description "artikel ilmiah" @default.
- Q81604961 description "artikull shkencor" @default.
- Q81604961 description "artikulong pang-agham" @default.
- Q81604961 description "artykuł naukowy" @default.
- Q81604961 description "artículo científico publicado en 2005" @default.
- Q81604961 description "artículu científicu" @default.
- Q81604961 description "bilimsel makale" @default.
- Q81604961 description "bài báo khoa học" @default.
- Q81604961 description "naučni članak" @default.
- Q81604961 description "scienca artikolo" @default.
- Q81604961 description "scientific article published in April 2005" @default.
- Q81604961 description "scientific article published in April 2005" @default.
- Q81604961 description "scientific article published on 01 April 2005" @default.
- Q81604961 description "teaduslik artikkel" @default.
- Q81604961 description "tieteellinen artikkeli" @default.
- Q81604961 description "tudományos cikk" @default.
- Q81604961 description "vedecký článok" @default.
- Q81604961 description "vetenskaplig artikel" @default.
- Q81604961 description "videnskabelig artikel udgivet april 2005" @default.
- Q81604961 description "vitenskapelig artikkel" @default.
- Q81604961 description "vitskapeleg artikkel" @default.
- Q81604961 description "vědecký článek" @default.
- Q81604961 description "wetenschappelijk artikel" @default.
- Q81604961 description "wissenschaftlicher Artikel" @default.
- Q81604961 description "επιστημονικό άρθρο" @default.
- Q81604961 description "мақолаи илмӣ" @default.
- Q81604961 description "наукова стаття, опублікована у квітні 2005" @default.
- Q81604961 description "научна статия" @default.
- Q81604961 description "научная статья" @default.
- Q81604961 description "научни чланак" @default.
- Q81604961 description "научни чланак" @default.
- Q81604961 description "գիտական հոդված հրատարակված 2005 թվականի ապրիլի 1-ին" @default.
- Q81604961 description "מאמר מדעי" @default.
- Q81604961 description "مقالة علمية نشرت في أبريل 2005" @default.
- Q81604961 description "এপ্রিল ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q81604961 description "บทความทางวิทยาศาสตร์" @default.
- Q81604961 description "სამეცნიერო სტატია" @default.
- Q81604961 name "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib" @default.
- Q81604961 name "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib" @default.
- Q81604961 type Item @default.
- Q81604961 label "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib" @default.
- Q81604961 label "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib" @default.
- Q81604961 prefLabel "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib" @default.
- Q81604961 prefLabel "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib" @default.
- Q81604961 P1433 Q81604961-281C7D64-448D-4C32-A0D3-3D39FEA8FE38 @default.
- Q81604961 P1476 Q81604961-C7C8CDA9-A074-4071-9871-0A3626A48AE8 @default.
- Q81604961 P2093 Q81604961-455F0EC9-C169-4340-9EE2-B2EE6FAFEB7B @default.
- Q81604961 P2093 Q81604961-633E70D3-AC01-4486-924B-C52DAEF03C02 @default.
- Q81604961 P2093 Q81604961-65627F9C-4CDE-41B3-BF25-43E57454A96E @default.
- Q81604961 P2093 Q81604961-65D3BE74-D678-46D5-A654-BF7D8A479F6C @default.
- Q81604961 P2093 Q81604961-C45F6E21-9505-4E6C-AF6F-25B7068DC15E @default.
- Q81604961 P2093 Q81604961-EF6A45C2-0EB3-461F-A841-E1A9236EC3A4 @default.
- Q81604961 P304 Q81604961-E5BE5415-46CB-466A-8F39-B33DCB4DBC5A @default.
- Q81604961 P31 Q81604961-7EFC7B23-8B82-49CC-914B-EE280D3B1006 @default.
- Q81604961 P356 Q81604961-1212C580-990B-4E7D-AE99-C232DAEED4DC @default.
- Q81604961 P433 Q81604961-4328B575-FB7C-49AC-B0FD-5E7D59395E53 @default.
- Q81604961 P478 Q81604961-B3185DF1-DAFD-4921-BBFF-1C62D34AAF44 @default.
- Q81604961 P50 Q81604961-205DC190-EF11-4FFD-B951-1AB70136706D @default.
- Q81604961 P577 Q81604961-8ACDDF3B-FDED-474D-935A-4048E816E56B @default.
- Q81604961 P698 Q81604961-85A1ECF1-997B-42FC-8196-131BC468864D @default.
- Q81604961 P921 Q81604961-63838BA9-56B3-4322-9B5A-C631495A6980 @default.
- Q81604961 P921 Q81604961-7E18F61F-E564-404E-8745-9DFD3174A951 @default.
- Q81604961 P921 Q81604961-B5B97325-9DFB-4B63-845E-FD82528DB3B1 @default.
- Q81604961 P356 0008-5472.CAN-04-2416 @default.
- Q81604961 P698 15805252 @default.
- Q81604961 P1433 Q326097 @default.
- Q81604961 P1476 "The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients" @default.
- Q81604961 P2093 "Alfred H Schinkel" @default.
- Q81604961 P2093 "Dick Pluim" @default.
- Q81604961 P2093 "Greta Cipriani" @default.
- Q81604961 P2093 "Olaf van Tellingen" @default.
- Q81604961 P2093 "Pauline Breedveld" @default.
- Q81604961 P2093 "Peter Wielinga" @default.
- Q81604961 P304 "2577-2582" @default.
- Q81604961 P31 Q13442814 @default.
- Q81604961 P356 "10.1158/0008-5472.CAN-04-2416" @default.
- Q81604961 P433 "7" @default.
- Q81604961 P478 "65" @default.